NBY News and Press, NovaBay Pharmaceuticals Inc. From 03/31/21

NovaBay ® Pharmaceuticals, Inc . (NYSE American: NBY), a pharmaceutical company focusing on commercializing Avenova for the eye care market, announces the availability of its new Warm Eye Compress on Amazon.com and on Avenova.com . This new, reusable heated eye comp...

NovaBay Pharmaceuticals, Inc. (NBY) Q4 2020 Earnings Conference Call March 25, 2021 4:30 PM ET Company Participants Jody Cain – Investor Relations-LHA Justin Hall – President and Chief Executive Officer Andy Jones – Chief Financial Officer Conference Call Participants Jef...

NovaBay (NBY): Q4 GAAP EPS of -$0.04 in-line.Revenue of $1.89M (+11.2% Y/Y) misses by $0.59M.Press Release For further details see: NovaBay EPS in-line, misses on revenue

Avenova ® unit sales set record for second consecutive quarter Net product revenue increased 51% for 2020 Exited 2020 with $12.0 million in cash and equivalents Avenova access expanded to CVS stores and CVS online Conference call begins at ...

NovaBay ® Pharmaceuticals, Inc. (NYSE American: NBY) announces it will report financial results for the three and 12 months ended December 31, 2020 after market close on Thursday, March 25, 2021 and will hold an investment community conference call that day at 4:30 p.m. Eas...

NovaBay Pharmaceuticals (NYSE American: NBY), a pharmaceutical company focusing on commercializing Avenova ® for the eye care market and CelleRx ® Clinical Reset™ for the beauty market, announces that management will hold one-on-one investor meetings at the Virt...

No matter how you break up your portfolio, you may want to set aside a potion for small-cap penny stocks. The main reason for that: small-caps are far-outperforming the broader markets. If you take a look at benchmark ETFs like the S&P SPY, the Nasdaq QQQ, and the Russell Small-Cap IWM,...

Issuing a letter to investors, NovaBay Pharmaceuticals (NBY) said that the current liquidity level of the company would be sufficient to support its 2021 operations. The company shares are up ~12.0% in premarket.NovaBay focused on non-antibiotic anti-infective products also announce...

NovaBay Pharmaceuticals (NYSE American: NBY) issued the following Letter to Stockholders: To My Fellow Stockholders: NovaBay Pharmaceuticals enters 2021 focused on growing sales of our high-quality, differentiated consumer products: Avenova ® , the premier antimicro...

Gainers: Live Ventures (LIVE) +87%.GameStop (GME) +63%.Exela Technologies (XELA) +51%.AMMO (POWW) +41%.Castor Maritime (CTRM) +35%.Acorda Therapeutics (ACOR) +32%.Root (ROOT) +32%.Ondas Holdings (ONDS) +30%.NuCana (NCNA) +26%.Foresight Autonomous (FRSX) +26%.Losers:&#...